Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196245 · ClinicalTrials.gov registry record
NK Cell Mediated Influenza Immunity During Pregnancy
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 94
- Enrollment target
NCT03196245: Clinical Trial study, sponsored by Stanford University.
NCT03196245 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196245 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 94 participants
- Enrollment target
Study Summary
Pregnant women have increased morbidity and mortality due to infection with influenza. Changes in T cell function have been proposed as possible mechanisms for this finding. We believe that pregnancy induced changes in NK cell phenotype and function also impact influenza immunity. This study will compare the immune response of pregnant women and controls to TIV influenza vaccination as a surrogate for infection. In addition pregnant women with flu like illness will be enrolled to evaluate changes in immune response following influenza infection as compared to vaccination.
Primary Outcome
We are assessing the NK cell repertoire and anti-influenza NK cell function
Interventions
- OTHER There is no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2012-08-14 |
| Est. Completion | 2019-04-01 |
Why NCT03196245 stopped before completion
NCT03196245 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention. is the first listed.
NCT03196245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03196245 about?
NCT03196245 is a clinical study titled "NK Cell Mediated Influenza Immunity During Pregnancy". Pregnant women have increased morbidity and mortality due to infection with influenza. Changes in T cell function have been proposed as possible mechanisms for this finding. We believe that pregnancy induced changes in NK cell phenotype and function also impact influenza immunity. This study will co...
What is the current status of trial NCT03196245?
This trial is currently terminated. The enrollment target is 94 participants. The study started on 2012-08-14. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03196245?
The interventions under investigation include: There is no intervention. (OTHER).
Who is sponsoring clinical trial NCT03196245?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI